512 related articles for article (PubMed ID: 28073972)
1. Awareness and attitude regarding reproductive options of persons carrying a BRCA mutation and their partners.
Gietel-Habets JJ; de Die-Smulders CE; Derks-Smeets IA; Tibben A; Tjan-Heijnen VC; van Golde R; Gomez-Garcia E; Kets CM; van Osch LA
Hum Reprod; 2017 Mar; 32(3):588-597. PubMed ID: 28073972
[TBL] [Abstract][Full Text] [Related]
2. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer.
Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA
Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131
[TBL] [Abstract][Full Text] [Related]
3. Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors.
Derks-Smeets IA; de Die-Smulders CE; Mackens S; van Golde R; Paulussen AD; Dreesen J; Tournaye H; Verdyck P; Tjan-Heijnen VC; Meijer-Hoogeveen M; De Greve J; Geraedts J; De Rycke M; Bonduelle M; Verpoest WM
Breast Cancer Res Treat; 2014 Jun; 145(3):673-81. PubMed ID: 24748567
[TBL] [Abstract][Full Text] [Related]
4. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort.
Fortuny D; Balmaña J; Graña B; Torres A; Ramón y Cajal T; Darder E; Gadea N; Velasco A; López C; Sanz J; Alonso C; Brunet J
Hum Reprod; 2009 Apr; 24(4):1000-6. PubMed ID: 19112076
[TBL] [Abstract][Full Text] [Related]
5. Professionals' knowledge, attitude and referral behaviour of preimplantation genetic diagnosis for hereditary breast and ovarian cancer.
Gietel-Habets JJG; de Die-Smulders CEM; Tjan-Heijnen VCG; Derks-Smeets IAP; van Golde R; Gomez-Garcia E; van Osch LADM
Reprod Biomed Online; 2018 Feb; 36(2):137-144. PubMed ID: 29242113
[TBL] [Abstract][Full Text] [Related]
6. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer.
Menon U; Harper J; Sharma A; Fraser L; Burnell M; ElMasry K; Rodeck C; Jacobs I
Hum Reprod; 2007 Jun; 22(6):1573-7. PubMed ID: 17428877
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer, BRCA mutations, and attitudes regarding pregnancy and preimplantation genetic diagnosis.
Woodson AH; Muse KI; Lin H; Jackson M; Mattair DN; Schover L; Woodard T; McKenzie L; Theriault RL; Hortobágyi GN; Arun B; Peterson SK; Profato J; Litton JK
Oncologist; 2014 Aug; 19(8):797-804. PubMed ID: 24951607
[TBL] [Abstract][Full Text] [Related]
8. Reproductive decision-making in young female carriers of a BRCA mutation.
Donnelly LS; Watson M; Moynihan C; Bancroft E; Evans DG; Eeles R; Lavery S; Ormondroyd E
Hum Reprod; 2013 Apr; 28(4):1006-12. PubMed ID: 23293217
[TBL] [Abstract][Full Text] [Related]
9. Recurrent miscarriage in translocation carriers: no differences in clinical characteristics between couples who accept and couples who decline PGD.
De Krom G; Arens YH; Coonen E; Van Ravenswaaij-Arts CM; Meijer-Hoogeveen M; Evers JL; Van Golde RJ; De Die-Smulders CE
Hum Reprod; 2015 Feb; 30(2):484-9. PubMed ID: 25432924
[TBL] [Abstract][Full Text] [Related]
10. Support needs of couples with hereditary breast and ovarian cancer during reproductive decision making.
Gietel-Habets JJG; de Die-Smulders CEM; Derks-Smeets IAP; Tibben A; Tjan-Heijnen VCG; van Golde R; Gomez-Garcia E; van Osch LADM
Psychooncology; 2018 Jul; 27(7):1795-1801. PubMed ID: 29644780
[TBL] [Abstract][Full Text] [Related]
11. Reproductive Decision-Making in Women with BRCA1/2 Mutations.
Chan JL; Johnson LNC; Sammel MD; DiGiovanni L; Voong C; Domchek SM; Gracia CR
J Genet Couns; 2017 Jun; 26(3):594-603. PubMed ID: 27796678
[TBL] [Abstract][Full Text] [Related]
12. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis.
Julian-Reynier C; Fabre R; Coupier I; Stoppa-Lyonnet D; Lasset C; Caron O; Mouret-Fourme E; Berthet P; Faivre L; Frenay M; Gesta P; Gladieff L; Bouhnik AD; Protière C; Noguès C
Genet Med; 2012 May; 14(5):527-34. PubMed ID: 22241105
[TBL] [Abstract][Full Text] [Related]
13. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
[TBL] [Abstract][Full Text] [Related]
14. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis.
Ormondroyd E; Donnelly L; Moynihan C; Savona C; Bancroft E; Evans DG; Eeles R; Lavery S; Watson M
Eur J Hum Genet; 2012 Jan; 20(1):4-10. PubMed ID: 21811309
[TBL] [Abstract][Full Text] [Related]
15. Knowledge, acceptability and personal attitude toward pre-implantation 1 genetic testing (PGT) and pre-natal diagnosis (PND) for females carrying BRCA pathogenic variant according to fertility preservation experience.
Dervin T; Ranisavjevic N; Laot L; Mayeur A; Duperier C; Steffann J; Borghese R; Stoppa-Lyonnet D; Frydman N; Benachi A; Sonigo C; Grynberg M
J Assist Reprod Genet; 2023 Jun; 40(6):1381-1390. PubMed ID: 37154838
[TBL] [Abstract][Full Text] [Related]
16. Professionals assess the acceptability of preimplantation genetic diagnosis and prenatal diagnosis for managing inherited predisposition to cancer.
Julian-Reynier C; Chabal F; Frebourg T; Lemery D; Noguès C; Puech F; Stoppa-Lyonnet D
J Clin Oncol; 2009 Sep; 27(27):4475-80. PubMed ID: 19704065
[TBL] [Abstract][Full Text] [Related]
17. Depression, pregnancy-related anxiety and parental-antenatal attachment in couples using preimplantation genetic diagnosis.
Winter C; Van Acker F; Bonduelle M; Van Berkel K; Belva F; Liebaers I; Nekkebroeck J
Hum Reprod; 2016 Jun; 31(6):1288-99. PubMed ID: 27106283
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive embryo testing. Experts' opinions regarding future directions: an expert panel study on comprehensive embryo testing.
Hens K; Dondorp WJ; Geraedts JP; de Wert GM
Hum Reprod; 2013 May; 28(5):1418-25. PubMed ID: 23416277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
